Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Orphanet Journal of Rare Diseases
Published in: Orphanet Journal of Rare Diseases 1/2014

Open Access 01-12-2014 | Research

Assessing the role of multiple pregnancies in the association between tetralogy of Fallot and assisted reproductive techniques: a path-analysis approach

Authors: Karim Tararbit, Nathalie Lelong, Lucile Houyel, Damien Bonnet, François Goffinet, Babak Khoshnood

Published in: Orphanet Journal of Rare Diseases | Issue 1/2014

Login to get access

Abstract

Background

Assisted reproductive techniques (ART) are associated with a higher risk of tetralogy of Fallot (TOF) and multiple pregnancies may be associated with a higher risk of congenital anomalies. We assessed the extent to which the association between ART and risk of TOF may be mediated by the higher risk of multiple pregnancies associated with ART.

Methods

We conducted a case–control study using population-based data from the Paris Registry of Congenital Malformations for the period 1987–2009 and a cohort study of congenital heart defects (EPICARD). The study population included 395 cases of TOF and 4104 malformed controls with no known associations with ART. The analysis was based on a path-analysis model using a counterfactual approach, which allows decomposition of the total effect of ART into an indirect effect (that mediated by the association between ART and multiple pregnancies) and a direct effect.

Results

ART (all methods combined) were associated with a 2.6-fold higher odds of TOF after adjustment for maternal and paternal characteristics and year of birth (adjusted OR 2.6, 95% CI, 1.5-4.5). Most (79%) of the effect associated with ART was a direct effect (i.e., not mediated by multiple pregnancies), whereas 21% of the effect of ART was due to its association with multiple pregnancies (i.e., the indirect effect). In vitro fertilization with intracytoplasmic sperm injection was associated with a 3.5-fold higher odds of TOF (adjusted OR 3.5, 95% CI, 1.1-11.2); 11% of this effect was mediated through the association of ICSI with multiple pregnancies.

Conclusions

By far, most of the higher risk of TOF associated with ART is a direct effect and only a small proportion of the effect may be mediated by multiple pregnancies.
Appendix
Available only for authorised users
Literature
1.
Blondel B, Kaminski M: Trends in the occurrence, determinants, and consequences of multiple births. Semin Perinatol. 2002, 26 (4): 239-249. 10.1053/sper.2002.34775.CrossRefPubMed
2.
Nyboe Andersen A, Goossens V, Bhattacharya S, Ferraretti AP, Kupka MS, de Mouzon J, Nygren KG: Assisted reproductive technology and intrauterine inseminations in Europe, 2005: results generated from European registers by ESHRE: ESHRE. The European IVF monitoring programme (EIM), for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod. 2009, 24 (6): 1267-1287. 10.1093/humrep/dep035.CrossRefPubMed
3.
Bower C, Hansen M: Assisted reproductive technologies and birth outcomes: overview of recent systematic reviews. Reprod Fertil Dev. 2005, 17 (3): 329-333. 10.1071/RD04095.CrossRefPubMed
4.
Buckett WM, Tan SL: Congenital abnormalities in children born after assisted reproductive techniques: how much is associated with the presence of infertility and how much with its treatment?. Fertil Steril. 2005, 84 (5): 1318-1319. 10.1016/j.fertnstert.2005.04.065. discussion 1327CrossRefPubMed
5.
Hansen M, Bower C, Milne E, de Klerk N, Kurinczuk JJ: Assisted reproductive technologies and the risk of birth defects–a systematic review. Hum Reprod. 2005, 20 (2): 328-338.CrossRefPubMed
6.
Hansen M, Kurinczuk JJ, Bower C, Webb S: The risk of major birth defects after intracytoplasmic sperm injection and in vitro fertilization. N Engl J Med. 2002, 346 (10): 725-730. 10.1056/NEJMoa010035.CrossRefPubMed
7.
Klemetti R, Gissler M, Sevon T, Koivurova S, Ritvanen A, Hemminki E: Children born after assisted fertilization have an increased rate of major congenital anomalies. Fertil Steril. 2005, 84 (5): 1300-1307. 10.1016/j.fertnstert.2005.03.085.CrossRefPubMed
8.
Koivurova S, Hartikainen AL, Gissler M, Hemminki E, Sovio U, Jarvelin MR: Neonatal outcome and congenital malformations in children born after in-vitro fertilization. Hum Reprod. 2002, 17 (5): 1391-1398. 10.1093/humrep/17.5.1391.CrossRefPubMed
9.
Olson CK, Keppler-Noreuil KM, Romitti PA, Budelier WT, Ryan G, Sparks AE, Van Voorhis BJ: In vitro fertilization is associated with an increase in major birth defects. Fertil Steril. 2005, 84 (5): 1308-1315. 10.1016/j.fertnstert.2005.03.086.CrossRefPubMed
10.
Schieve LA, Rasmussen SA, Reefhuis J: Risk of birth defects among children conceived with assisted reproductive technology: providing an epidemiologic context to the data. Fertil Steril. 2005, 84 (5): 1320-1324. 10.1016/j.fertnstert.2005.04.066. discussion 1327CrossRefPubMed
11.
Davies MJ, Moore VM, Willson KJ, Van Essen P, Priest K, Scott H, Haan EA, Chan A: Reproductive technologies and the risk of birth defects. N Engl J Med. 2012, 366 (19): 1803-1813. 10.1056/NEJMoa1008095.CrossRefPubMed
12.
Reefhuis J, Honein MA, Schieve LA, Correa A, Hobbs CA, Rasmussen SA: Assisted reproductive technology and major structural birth defects in the United States. Hum Reprod. 2009, 24 (2): 360-366. 10.1093/humrep/den387.CrossRefPubMed
13.
Reefhuis J, Honein MA, Schieve LA, Rasmussen SA: Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997–2005. Hum Reprod. 2011, 26 (2): 451-457. 10.1093/humrep/deq313.CrossRefPubMed
14.
Tararbit K, Houyel L, Bonnet D, De Vigan C, Lelong N, Goffinet F, Khoshnood B: Risk of congenital heart defects associated with assisted reproductive technologies: a population-based evaluation. Eur Heart J. 2011, 32 (4): 500-508. 10.1093/eurheartj/ehq440.CrossRefPubMed
15.
Tararbit K, Lelong N, Thieulin AC, Houyel L, Bonnet D, Goffinet F, Khoshnood B: The risk for four specific congenital heart defects associated with assisted reproductive techniques: a population-based evaluation. Hum Reprod. 2013, 28 (2): 367-374. 10.1093/humrep/des400.CrossRefPubMedPubMedCentral
16.
Glinianaia SV, Rankin J, Wright C: Congenital anomalies in twins: a register-based study. Hum Reprod. 2008, 23 (6): 1306-1311. 10.1093/humrep/den104.CrossRefPubMed
17.
Weber MA, Sebire NJ: Genetics and developmental pathology of twinning. Semin Fetal Neonatal Med. 2010, 15 (6): 313-318. 10.1016/j.siny.2010.06.002.CrossRefPubMed
18.
Bahtiyar MO, Dulay AT, Weeks BP, Friedman AH, Copel JA: Prevalence of congenital heart defects in monochorionic/diamniotic twin gestations: a systematic literature review. J Ultrasound Med. 2007, 26 (11): 1491-1498.PubMed
19.
Campbell KH, Cope JA, Ozan Bahtiyar M: Congenital heart defects in twin gestations. Minerva Ginecol. 2009, 61 (3): 239-244.PubMed
20.
Manning N: The influence of twinning on cardiac development. Early Hum Dev. 2008, 84 (3): 173-179. 10.1016/j.earlhumdev.2008.01.009.CrossRefPubMed
21.
Hajdu J, Beke A, Marton T, Hruby E, Pete B, Papp Z: Congenital heart diseases in twin pregnancies. Fetal Diagn Ther. 2006, 21 (2): 198-203. 10.1159/000089303.CrossRefPubMed
22.
Cocchi G, Gualdi S, Bower C, Halliday J, Jonsson B, Myrelid A, Mastroiacovo P, Amar E, Bakker MK, Correa A, Doray B, Melve KK, Koshnood B, Landau D, Mutchinick OM, Pierini A, Ritvanen A, Ruddock V, Scarano G, Sibbald B, Sipek A, Tenconi R, Tucker D, Anneren G: International trends of down syndrome 1993–2004: births in relation to maternal age and terminations of pregnancies. Birth Defects Res A Clin Mol Teratol. 2010, 88 (6): 474-479. 10.1002/bdra.20666.CrossRefPubMed
23.
24.
Greenlees R, Neville A, Addor MC, Amar E, Arriola L, Bakker M, Barisic I, Boyd PA, Calzolari E, Doray B, Draper E, Vollset SE, Garne E, Gatt M, Haeusler M, Kallen K, Khoshnood B, Latos-Bielenska A, Martinez-Frias ML, Materna-Kiryluk A, Dias CM, McDonnell B, Mullaney C, Nelen V, O’Mahony M, Pierini A, Queisser-Luft A, Randrianaivo-Ranjatoelina H, Rankin J, Rissmann A, et al: Paper 6: EUROCAT member registries: organization and activities. Birth Defects Res A Clin Mol Teratol. 2011, 91 (Suppl 1): S51-S100.CrossRefPubMed
25.
Khoshnood B, Greenlees R, Loane M, Dolk H: Paper 2: EUROCAT public health indicators for congenital anomalies in Europe. Birth Defects Res A Clin Mol Teratol. 2011, 91 (Suppl 1): S16-S22.CrossRefPubMedPubMedCentral
26.
Khoshnood B, Lelong N, Houyel L, Thieulin AC, Jouannic JM, Magnier S, Delezoide AL, Magny JF, Rambaud C, Bonnet D, Goffinet F: Prevalence, timing of diagnosis and mortality of newborns with congenital heart defects: a population-based study. Heart. 2012, 98 (22): 1667-1673. 10.1136/heartjnl-2012-302543.CrossRefPubMed
27.
Hook EB: Normal or affected controls in case–control studies of congenital malformations and other birth defects: reporting bias issues. Epidemiology. 1993, 4 (2): 182-184. 10.1097/00001648-199303000-00017.CrossRefPubMed
28.
Smith LK, Budd JL, Field DJ, Draper ES: Socioeconomic inequalities in outcome of pregnancy and neonatal mortality associated with congenital anomalies: population based study. BMJ. 2011, 343: d4306-10.1136/bmj.d4306.CrossRefPubMedPubMedCentral
29.
Vrijheid M, Dolk H, Stone D, Abramsky L, Alberman E, Scott JE: Socioeconomic inequalities in risk of congenital anomaly. Arch Dis Child. 2000, 82 (5): 349-352. 10.1136/adc.82.5.349.CrossRefPubMedPubMedCentral
30.
31.
Erikson R, Goldthorpe JH, Jackson M, Yaish M, Cox DR: On class differentials in educational attainment. Proc Natl Acad Sci U S A. 2005, 102 (27): 9730-9733. 10.1073/pnas.0502433102.CrossRefPubMedPubMedCentral
32.
Kuwata T, Matsubara S, Ohkuchi A, Watanabe T, Izumi A, Honma Y, Yada Y, Shibahara H, Suzuki M: The risk of birth defects in dichorionic twins conceived by assisted reproductive technology. Twin Res. 2004, 7 (3): 223-227. 10.1375/136905204774200488.CrossRefPubMed
33.
Apitz C, Webb GD, Redington AN: Tetralogy of Fallot. Lancet. 2009, 374 (9699): 1462-1471. 10.1016/S0140-6736(09)60657-7.CrossRefPubMed
34.
Di Felice V, Zummo G: Tetralogy of fallot as a model to study cardiac progenitor cell migration and differentiation during heart development. Trends Cardiovasc Med. 2009, 19 (4): 130-135. 10.1016/j.tcm.2009.07.004.CrossRefPubMed
35.
Bittel DC, Butler MG, Kibiryeva N, Marshall JA, Chen J, Lofland GK, O’Brien JE: Gene expression in cardiac tissues from infants with idiopathic conotruncal defects. BMC Med Genomics. 2011, 4: 1-10.1186/1755-8794-4-1.CrossRefPubMedPubMedCentral
36.
Bruneau BG: The developmental genetics of congenital heart disease. Nature. 2008, 451 (7181): 943-948. 10.1038/nature06801.CrossRefPubMed
37.
O’Brien JE, Kibiryeva N, Zhou XG, Marshall JA, Lofland GK, Artman M, Chen J, Bittel DC: Noncoding RNA expression in myocardium from infants with tetralogy of Fallot. Circ Cardiovasc Genet. 2012, 5 (3): 279-286. 10.1161/CIRCGENETICS.111.961474.CrossRefPubMed
38.
van Weerd JH, Koshiba-Takeuchi K, Kwon C, Takeuchi JK: Epigenetic factors and cardiac development. Cardiovasc Res. 2011, 91 (2): 203-211. 10.1093/cvr/cvr138.CrossRefPubMedPubMedCentral
39.
Hutson MR, Kirby ML: Model systems for the study of heart development and disease. Cardiac neural crest and conotruncal malformations. Semin Cell Dev Biol. 2007, 18 (1): 101-110. 10.1016/j.semcdb.2006.12.004.CrossRefPubMedPubMedCentral
40.
Jauniaux E, Ben-Ami I, Maymon R: Do assisted-reproduction twin pregnancies require additional antenatal care?. Reprod Biomed Online. 2013, 26 (2): 107-119. 10.1016/j.rbmo.2012.11.008.CrossRefPubMed
41.
Pinborg A, Wennerholm UB, Romundstad LB, Loft A, Aittomaki K, Soderstrom-Anttila V, Nygren KG, Hazekamp J, Bergh C: Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis. Hum Reprod Update. 2013, 19 (2): 87-104. 10.1093/humupd/dms044.CrossRefPubMed
42.
Sazonova A, Kallen K, Thurin-Kjellberg A, Wennerholm UB, Bergh C: Factors affecting obstetric outcome of singletons born after IVF. Hum Reprod. 2011, 26 (10): 2878-2886. 10.1093/humrep/der241.CrossRefPubMed
43.
van Oppenraaij RH, Jauniaux E, Christiansen OB, Horcajadas JA, Farquharson RG, Exalto N: Predicting adverse obstetric outcome after early pregnancy events and complications: a review. Hum Reprod Update. 2009, 15 (4): 409-421. 10.1093/humupd/dmp009.CrossRefPubMed
44.
Botto LD, Mulinare J, Erickson JD: Occurrence of congenital heart defects in relation to maternal mulitivitamin use. Am J Epidemiol. 2000, 151 (9): 878-884. 10.1093/oxfordjournals.aje.a010291.CrossRefPubMed
45.
Blondel B, Lelong N, Kermarrec M, Goffinet F: Trends in perinatal health in France from 1995 to 2010. Results from the French National Perinatal Surveys. J Gynecol Obstet Biol Reprod (Paris). 2012, 41 (4): e1-e15. 10.1016/j.jgyn.2012.04.014.CrossRef
46.
Zhu JL, Basso O, Obel C, Bille C, Olsen J: Infertility, infertility treatment, and congenital malformations: Danish national birth cohort. BMJ. 2006, 333 (7570): 679-10.1136/bmj.38919.495718.AE.CrossRefPubMedPubMedCentral
Metadata
Title
Assessing the role of multiple pregnancies in the association between tetralogy of Fallot and assisted reproductive techniques: a path-analysis approach
Authors
Karim Tararbit
Nathalie Lelong
Lucile Houyel
Damien Bonnet
François Goffinet
Babak Khoshnood
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2014
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/1750-1172-9-27

Other articles of this Issue 1/2014

Orphanet Journal of Rare Diseases 1/2014 Go to the issue

Review

Pathognomonic oral profile of Enamel Renal Syndrome (ERS) caused by recessive FAM20A mutations

Research

Reimbursement of orphan drugs in Belgium: what (else) matters?

Research

Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency

Research

Follow-up on pediatric patients with bronchiolitis obliterans treated with corticosteroid pulse therapy

Research

The European Cystic Fibrosis Society Patient Registry: valuable lessons learned on how to sustain a disease registry

Research

Severity score for hereditary hemorrhagic telangiectasia